252577-85-8 Usage
Uses
Used in Veterinary Medicine:
1-(5-Nitropyridin-2-yl)-4-piperidinamine is used as an antibacterial agent in fish farming for the treatment of bacterial infections caused by Aeromonas, Pseudomonas, and Flexibacter species. It functions by disrupting the synthesis of DNA and RNA in bacteria, which ultimately leads to their death.
Used in Research for Human Medicine:
1-(5-Nitropyridin-2-yl)-4-piperidinamine has been investigated for potential use in the treatment of tuberculosis and other bacterial infections in humans. However, its application in human medicine is limited due to concerns regarding potential toxicity and the presence of alternative antibiotics with fewer side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 252577-85-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,5,7 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 252577-85:
(8*2)+(7*5)+(6*2)+(5*5)+(4*7)+(3*7)+(2*8)+(1*5)=158
158 % 10 = 8
So 252577-85-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N4O2/c11-8-3-5-13(6-4-8)10-2-1-9(7-12-10)14(15)16/h1-2,7-8H,3-6,11H2
252577-85-8Relevant academic research and scientific papers
NEW COMPOUNDS
-
Page/Page column 39, (2008/06/13)
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
-
, (2008/06/13)
The invention concerns compounds of formula (Ia) wherein R1arepresents hydrogen, an —S(O)z—(C1-C4)Alk group, a —CO(C1-C4)Alk group, an —NHSO2—(C1-C4)Alk group, an NCHl (C1-C4) Alk group, a 2-furyl group or a halogen; R2represents hydrogen or a (C1-C4)Alk group, a (C1-C4) alkoxyl group, a halogen, —COOH, —COO(C1-C4)Alk, —CN, —CONR3R4, —NO2, —SO2NH2, —NHSO2(C1-C4)Alk; m and n are independently 0, 1 or 2; R3and R4independently represent hydrogen or a (C1-C4)Alk group; Z is 1 or 2 and their salts or solvates, the pharmaceutical compositions that contain them, the process for their preparation, and intermediate synthesis products.
